Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Ustekinumab, (obg) Atc L04ac05 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Bulgaria Supply Of Medicinal Products For Dialysis Treatment And Solutions For Peritoneal Dialysis Treatment For The Needs Of Umbal Dr. Georgi Stranski Ead - Pleven 2027-01-14
Bulgaria "supply Of Medicinal Products For Dialysis Treatment And Solutions For Peritoneal Dialysis Treatment For The Needs Of "umbal Dr. Georgi Sztajn" Ead - Pleven 2027-01-14
Bulgaria Dsp Delivery Of Medical Devices For Neurosurgery 2027-01-15
Finland Dynamic Procurement System: Medicinal Products And Products Comparable To Them 2027-01-16
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Ambrisentan (atc Code According To Who 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Ambrisentan (atc Code According To Who: C02kx02) 2027-01-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who: V03ae02) 2027-01-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Sevelamer Hydrochloride (atc Code According To Who: V03ae02) 2027-01-31
Whats app